Scotland starts scrutiny of HCV-infected blood:
This article was originally published in Clinica
Executive Summary
The Scottish government is to hold an inquiry to determine whether haemophiliacs who contracted hepatitis C from contaminated blood products should receive compensation. It recently emerged that the heat treatment used to kill off viruses in blood products in Scotland had not been applied at a sufficiently high temperature and the products may have remained contaminated for up to one year after the UK government had declared them safe in 1986. Unlike haemophiliacs who were infected with HIV, compensation from the UK government has so far been denied to those with hepatitis C.